Alpha 2.0
Login Register
» Authors » Jean-Luc Olivier

Jean-Luc Olivier

Explore the profile of Jean-Luc Olivier including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 20
Citations 561
Followers 0
Related Specialties
Neurology
Physiology
Biochemistry
Top 10 Co-Authors
Thierry Pillot
Violette Koziel
Thierry Oster
Badreddine Kriem
Catherine Malaplate-Armand
Isabelle Sponne
Alexandre Fifre
Marie-Christine Escanye
Sabrina Florent-Bechard
Ihsen Youssef
Published In
FASEB J
J Alzheimers Dis
J Biol Chem
J Neurochem
FEBS Lett
Affiliations
Soon will be listed here.
Recent Articles
1.
The spectrum of biochemical alterations associated with organ dysfunction and inflammatory status and their association with disease outcomes in severe COVID-19: A longitudinal cohort and time-series design study
Oussalah A, Gleye S, Urmes I, Laugel E, Barbe F, Orlowski S, et al.
EClinicalMedicine . 2020 Sep; 27:100554. PMID: 32984786
Background: In patients with severe COVID-19, no data are available on the longitudinal evolution of biochemical abnormalities and their ability to predict disease outcomes. Methods: Using a retrospective, longitudinal cohort...
2.
Long-term ACE Inhibitor/ARB Use Is Associated With Severe Renal Dysfunction and Acute Kidney Injury in Patients With Severe COVID-19: Results From a Referral Center Cohort in the Northeast of France
Oussalah A, Gleye S, Urmes I, Laugel E, Callet J, Barbe F, et al.
Clin Infect Dis . 2020 Jul; 71(9):2447-2456. PMID: 32623470
Background: In patients with severe coronavirus disease 2019 (COVID-19), data are scarce and conflicting regarding whether chronic use of angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) influences disease...
3.
Epigenetic and Neurological Impairments Associated with Early Life Exposure to Persistent Organic Pollutants
Grova N, Schroeder H, Olivier J, Turner J
Int J Genomics . 2019 Feb; 2019:2085496. PMID: 30733955
The incidence of neurodevelopmental and neurodegenerative diseases worldwide has dramatically increased over the last decades. Although the aetiology remains uncertain, evidence is now growing that exposure to persistent organic pollutants...
4.
A 1-week extension of a ketogenic diet provides a further decrease in myocardial F-FDG uptake and a high detectability of myocarditis with FDG-PET
Clement A, Boutley H, Poussier S, Pierson J, Lhuillier M, Kolodziej A, et al.
J Nucl Cardiol . 2018 Aug; 27(2):612-618. PMID: 30128917
Background: Short periods of fasting and/or low-carbohydrate diet have been proven beneficial for decreasing the myocardial uptake of F-fluorodeoxyglucose (F-FDG) and enhancing the detection of inflammatory heart diseases by F-FDG...
5.
Dietary arachidonic acid increases deleterious effects of amyloid-β oligomers on learning abilities and expression of AMPA receptors: putative role of the ACSL4-cPLA balance
Thomas M, Paris C, Magnien M, Colin J, Pelleieux S, Coste F, et al.
Alzheimers Res Ther . 2017 Aug; 9(1):69. PMID: 28851448
Background: Polyunsaturated fatty acids play a crucial role in neuronal function, and the modification of these compounds in the brain could have an impact on neurodegenerative diseases such as Alzheimer's...
6.
Cerebrospinal Fluid Aβ42/Aβ40 as a Means to Limiting Tube- and Storage-Dependent Pre-Analytical Variability in Clinical Setting
Gervaise-Henry C, Watfa G, Albuisson E, Kolodziej A, Dousset B, Olivier J, et al.
J Alzheimers Dis . 2017 Mar; 57(2):437-445. PMID: 28269771
Background: Alzheimer's disease (AD) cerebrospinal fluid (CSF) biomarkers have recently been included in the criteria for AD diagnosis. Unfortunately, their wider use in routine and interpretation require more standardization, particularly...
7.
Additional use of Aβ₄₂/Aβ₄₀ ratio with cerebrospinal fluid biomarkers P-tau and Aβ₄₂ increases the level of evidence of Alzheimer's disease pathophysiological process in routine practice
Sauvee M, DidierLaurent G, Latarche C, Escanye M, Olivier J, Malaplate-Armand C
J Alzheimers Dis . 2014 Mar; 41(2):377-86. PMID: 24614902
Background: Cerebrospinal fluid (CSF) biomarkers have recently been included in the criteria for the diagnosis of Alzheimer's disease (AD). Since interpretation of CSF profile requires the combination of three parameters,...
8.
Brain region-specific immunolocalization of the lipolysis-stimulated lipoprotein receptor (LSR) and altered cholesterol distribution in aged LSR+/- mice
Stenger C, Pincon A, Hanse M, Royer L, Comte A, Koziel V, et al.
J Neurochem . 2012 Aug; 123(4):467-76. PMID: 22909011
Brain lipid homeostasis is important for maintenance of brain cell function and synaptic communications, and is intimately linked to age-related cognitive decline. Because of the blood-brain barrier's limiting nature, this...
9.
Up-regulation of hepatic lipolysis stimulated lipoprotein receptor by leptin: a potential lever for controlling lipid clearance during the postprandial phase
Stenger C, Hanse M, Pratte D, Mbala M, Akbar S, Koziel V, et al.
FASEB J . 2010 Jul; 24(11):4218-28. PMID: 20647547
As a hepatic receptor for triglyceride-rich lipoproteins, the lipolysis-stimulated lipoprotein receptor (LSR) may be involved in the dynamics of lipid distribution between the liver and peripheral tissues. Here, we explore...
10.
Ciliary neurotrophic factor cell-based delivery prevents synaptic impairment and improves memory in mouse models of Alzheimer's disease
Garcia P, Youssef I, Utvik J, Florent-Bechard S, Barthelemy V, Malaplate-Armand C, et al.
J Neurosci . 2010 Jun; 30(22):7516-27. PMID: 20519526
The development of novel therapeutic strategies for Alzheimer's disease (AD) represents one of the biggest unmet medical needs today. Application of neurotrophic factors able to modulate neuronal survival and synaptic...